Wednesday, November 12, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Rigetti Computing: Can Technological Promise Offset Mounting Financial Losses?

Dieter Jaworski by Dieter Jaworski
November 12, 2025
in AI & Quantum Computing, Analysis, Earnings, Nasdaq, Tech & Software
0
Rigetti Stock
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

Quantum computing represents one of the most promising technological frontiers, yet companies like Rigetti Computing face a critical challenge: balancing ambitious technological roadmaps against persistent financial underperformance. Following the release of its latest quarterly figures, the company’s stock declined by more than 5%, reflecting investor apprehension despite notable technical achievements.

A Deeper Look at the Financials

For the third quarter of 2025, Rigetti Computing reported revenue of $1.9 million. This figure marks an 18% decrease compared to the prior year and fell short of analyst expectations, which had been set at $2.2 million. This revenue contraction presents a puzzling contrast to the company’s recent commercial announcements. Rigetti secured orders valued at approximately $5.7 million for two of its 9-qubit quantum computers and entered into a three-year, $5.8 million contract with the Air Force Research Laboratory.

This divergence highlights a common characteristic of capital-intensive, growth-phase technology firms: a significant lag often exists between booking an order and recognizing the corresponding revenue.

Dissecting a $201 Million Loss

A headline-grabbing GAAP loss of $201 million for the quarter demands closer scrutiny. The underlying operational reality is less dire. The company’s adjusted loss came in at just $10.7 million, a figure that actually surpassed analyst forecasts. The massive discrepancy is primarily attributed to non-cash accounting losses stemming from the revaluation of stock options in a highly volatile market.

The actual operating loss was reported at $20.5 million. While such a burn rate is not unusual for a company in its development stage, sustaining these levels long-term is untenable without a substantial and accelerating revenue stream.

Should investors sell immediately? Or is it worth buying Rigetti?

A Substantial Cash Cushion Provides Runway

On a more positive note, Rigetti’s balance sheet shows significant strength. The company currently holds approximately $600 million in liquid assets, a notable increase from its position at the end of September. A substantial inflow of $46.5 million came from the exercise of stock warrants. This robust financial safety net affords Rigetti the necessary time to pursue its aggressive technological milestones:

  • Development of a 100+ qubit system with 99.5% gate fidelity by the end of 2025
  • A 150+ qubit system targeted for the end of 2026
  • A 1,000+ qubit system planned for the end of 2027

The central question for investors remains whether this timeline is sufficient to achieve market-ready, profitable technology.

Strategic Alliances and Market Volatility

To solidify its standing within the quantum ecosystem, Rigetti is increasingly focusing on strategic collaborations. Its partnership with NVIDIA on the NVQLink platform, along with cooperative efforts with Indian and American research institutions, signals a strategic pivot toward becoming an infrastructure provider for hybrid quantum-classical AI applications.

The success of this strategy is entirely dependent on when—or if—commercially viable quantum applications become a widespread reality. The market’s skepticism is palpable, reflected in the stock’s extreme volatility. Shares have swung from a low of $1.25 to a high of over $58 within a single twelve-month period, underscoring deep investor uncertainty regarding the timeline for meaningful commercial breakthroughs in quantum computing.

Ad

Rigetti Stock: Buy or Sell?! New Rigetti Analysis from November 12 delivers the answer:

The latest Rigetti figures speak for themselves: Urgent action needed for Rigetti investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 12.

Rigetti: Buy or sell? Read more here...

Tags: Rigetti
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Take-Two Stock
Earnings

Take-Two Shares Tumble as Grand Theft Auto VI Faces New Delay

November 12, 2025
Novo Nordisk Stock
Analysis

Novo Nordisk Shares: Sustainable Recovery or Temporary Bounce?

November 12, 2025
Tuniu Stock
Asian Markets

Tuniu Faces Nasdaq Delisting Deadline as Shares Languish

November 12, 2025
Next Post
Helmerich, Payne Stock

Helmerich & Payne Shares Approach Critical Juncture

QuantumScape Stock

Insider Selling Raises Questions About QuantumScape's Future

JinkoSolar Stock

JinkoSolar Shares Approach Critical Juncture

Recommended

Unitedhealth Stock

Wall Street’s Stark Divide Over UnitedHealth Shares

4 weeks ago
Fluence Energy Stock

Fluence Energy Expands Manufacturing Footprint Amid Stock Market Challenges

3 months ago
Macy's Stock

Macy’s Faces Critical Test with Upcoming Q2 Earnings Report

2 months ago
TRP stock news

Barclays PLC Reduces Stake in Kymera Therapeutics as Company Shows Potential for Growth and Innovation

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

ASML’s Asian Strategy: Balancing Korean Expansion Against Chinese Headwinds

Rite Aid’s Final Chapter: Shareholders Face Total Wipeout

Allakos Reaches Corporate Endpoint with Concentra Acquisition

Nel ASA Shares Surge on Landmark Hydrogen Contract

Clash of Titans: Palantir CEO and “Big Short” Investor Lock Horns Over AI Valuation

BioNTech Shares Surge on Upbeat Revenue Outlook

Trending

Take-Two Stock
Earnings

Take-Two Shares Tumble as Grand Theft Auto VI Faces New Delay

by Dieter Jaworski
November 12, 2025
0

Despite posting exceptional quarterly earnings, Take-Two Interactive witnessed its stock plummet by more than 8% in a...

Novo Nordisk Stock

Novo Nordisk Shares: Sustainable Recovery or Temporary Bounce?

November 12, 2025
Tuniu Stock

Tuniu Faces Nasdaq Delisting Deadline as Shares Languish

November 12, 2025
Asml Stock

ASML’s Asian Strategy: Balancing Korean Expansion Against Chinese Headwinds

November 12, 2025
Rite Aidration Stock

Rite Aid’s Final Chapter: Shareholders Face Total Wipeout

November 12, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Take-Two Shares Tumble as Grand Theft Auto VI Faces New Delay
  • Novo Nordisk Shares: Sustainable Recovery or Temporary Bounce?
  • Tuniu Faces Nasdaq Delisting Deadline as Shares Languish

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com